Patents by Inventor Moustapha Kassem

Moustapha Kassem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF MICRORNA-138 FOR THE TREATMENT OF BONE LOSS
    Publication number: 20160355804
    Abstract: There is provided nucleic acids (mir-138Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: January 7, 2016
    Publication date: December 8, 2016
    Inventors: Moustapha KASSEM, Basem ABDALLAH, Hanna TAIPALEENMAEKI, Sakari KAUPPINEN, Tilde ESKILDSEN, Jan STENVANG
  • Anabolic compounds for treating and preventing bone loss diseases
    Patent number: 9273006
    Abstract: There is provided compounds for treating bone loss diseases and for preventing bone loss. Specifically the present invention relates to compounds, preferable isoquinolene derivatives.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: March 1, 2016
    Assignees: SYDDANSK UNIVERSITET, REGION SYDDANMARK
    Inventors: Abbas Jafari, Li Chen, Moustapha Kassem, Basem Abdallah
  • ANABOLIC COMPOUNDS FOR TREATING AND PREVENTING BONE LOSS DISEASES
    Publication number: 20150126548
    Abstract: There is provided compounds for treating bone loss diseases and for preventing bone loss. Specifically the present invention relates to compounds, preferable isoquinolene derivatives.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 7, 2015
    Inventors: Abbas Jafari, Li Chen, Moustapha Kassem, Basem Abdallah
  • MODULATION OF MICRORNA-138 FOR THE TREATMENT OF BONE LOSS
    Publication number: 20140194491
    Abstract: There is provided nucleic acids (mir-138 Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 10, 2014
    Applicant: SYDDANSK UNIVERSITET
    Inventors: Moustapha Kassem, Basem Abdallah, Hanna Taipaleenmaeki, Sakari Kauppinen, Tilde Eskildsen, Jan Stenvang
  • Immortalized stem cells
    Publication number: 20030049236
    Abstract: The present invention discloses a method of immortalizing human stem cells by culturing human bone marrow stromal cells (hMSC), and transducting the cell cultures with a retroviral vector, comprising the human telomeric repeat subunit (hTRT) gene. Further, an immortalized stem cell line and its use are described. The immortalized stem cells may for example be used in the treatment of bone-fractures, bone loss associated with ageing and/or osteoporosis, and in tissue engineering.
    Type: Application
    Filed: July 26, 2002
    Publication date: March 13, 2003
    Applicant: Arhus Amt
    Inventors: Moustapha Kassem, Thomas G. Jensen, Suresh I. S. Rattan